Send to

Choose Destination
Eur J Obstet Gynecol Reprod Biol. 2009 Oct;146(2):188-92. doi: 10.1016/j.ejogrb.2009.04.007. Epub 2009 May 17.

The effects of topical isoflavones on postmenopausal skin: double-blind and randomized clinical trial of efficacy.

Author information

Division of Endocrinology Gynecology, Department of Gynecology, UNIFESP, Brazil.



The aim of this study was to evaluate the effects of estrogen and isoflavones on postmenopausal skin morphological parameters.


A randomized, double-blind, estrogen-controlled trial was performed on postmenopausal women treated in the Gynecology Department of the Federal University of São Paulo. This study was designed to analyze the effects of topical administration of estradiol and isoflavones on facial skin for 24 weeks. The participants were divided into two groups: G1-17-betaestradiol 0.01% (n=18) and G2-isoflavones 40% (genistein 4%, n=18). Skin biopsies were performed on each patient before and after the treatment. The skin samples were processed for histological analysis, stained with haematoxylin and eosin, and examined using light microscopy.


After 24 weeks of treatment, the estradiol group had a significant increase in skin parameters analyzed compared to the isoflavone group and to the baseline measurements: epidermal thickness (a 75% increase in the estrogen group and 20% in the isoflavone group), number of dermal papillae (a rise of 125% with estrogen, no significant gain with isoflavones), fibroblasts (a 123% accretion with estradiol, no significant gain with isoflavones), and vessels (a 77% increase with estrogen and 36% with isoflavones).


Our data suggest that estrogens may have a stronger effect on histomorphometrical parameters than isoflavones.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center